Hepatitis C virus (HCV), West Nile virus (WNV), Japanese encephalitis virus ( JEV), and dengue virus (DENV) are members of Flaviviridae. They are deadly human pathogens and new and better therapeutic strategies are desperately needed. However, there are considerable barriers to the development of anti-Flaviviridae therapeutics, including the persistence of the virus, its genetic diversity during replication in the host and, for example, in the case of HCV, the lack of reproducible infectious culture systems. Similarities in the key Flaviviridae enzymes (with respect to conserved subdomain organization and arrangement of structural motifs) may indicate the potential usefulness of ribonucleoside analogues in the treatment of these viral infections. Over the last few years our understanding of the Flaviviridae replication cycle and the key enzymes involved in it has increased, giving hope for development of new antiviral agents.
Introduction
Hepatitis C virus (HCV), West Nile virus (WNV), Japanese encephalitis virus ( JEV), and dengue virus (DENV) are members of Flaviviridae. They are deadly human pathogens and new and better therapeutic strategies are desperately needed. However, there are considerable barriers to the development of anti-Flaviviridae therapeutics, including the persistence of the virus, its genetic diversity during replication in the host and, for example, in the case of HCV, the lack of reproducible infectious culture systems. Similarities in the key Flaviviridae enzymes (with respect to conserved subdomain organization and arrangement of structural motifs) may indicate the potential usefulness of ribonucleoside analogues in the treatment of these viral infections. Over the last few years our understanding of the Flaviviridae replication cycle and the key enzymes involved in it has increased, giving hope for development of new antiviral agents.
The Flaviviridae genome is a positive-stranded RNA, with a single open reading frame that translates into a single polyprotein. This polyprotein is co-and post-translationally processed by cellular and viral proteases into structural and non-structural (NS) proteins (Rosenberg, 2001) . Among the NS proteins, NS3 and NS5 -the major components of the so called 'replication complex' -appear to be the most promising targets for antiviral therapy because of their well-characterized enzymatic activities (Tan et A range of knock out experiments in which the helicase or polymerase activities were switched off demonstrated the crucial role of these enzymes in Flaviviridae replication (Matusan et al., 2001) . Hence compounds that block or at least reduce the activities of NTPase/helicase or RdRp could act as inhibitors of viral replication (Borowski et al., 2002) .
Since the reactions mediated by both enzymes are nucleoside 5′-triphosphate (NTP)-dependent, it is conceivable that non-hydrolysable NTP analogues, which do not substitute for NTP in RNA unwinding or RNA synthesis reactions, could serve as a basis for the development of inhibitors of NTPase/helicase and/or RdRp activities. The adenosine analogue, 5′-O-(4-fluorosulphphonylbenzoyl)-adenosine (FSBA) (Figure 1 ), has been found to react irreversibly with many enzymes which use NTPs as substrates, such as kinases, ATPases, and polymerases (Colman, 1983) . This compound might be considered an analogue of ATP or ADP. The structure and size of FSBA is such that it resembles ATP, and its reactive sulphonyl fluoride moiety may occupy a position similar to that of the β-and γ-phosphate in NTP (Wyatt & Colman, 1977) . Related purine derivatives were synthesized: 5′-O-(4-fluorosulphonylbenzoyl)-guanosine (FSBG) (Pal et al., 1978) , shown to react specifically with GTP binding sites in glutamate dehydrogenase ( Jadus et al., 1981) and pyruvate kinase (Tomich et al., 1981) , and 5′-O-(4-fluorosulphonylbenzoyl)-inosine (FSBI) (Williamson & Meister, 1982) , which reacted with 5-oxo-prolinase.
Non-hydrolysable ATP analogues do not substitute for ATP in the RNA unwinding reaction. It was pointed out that using ATP analogues, adenosine-5′-(3-thiotriphoshate) (ATP-γ-S) or β, γ-methylene ATP (AMP-PCP) (Gallinari et al., 1998) , only a low level of inhibition of unwinding activity of NTPase/helicase of HCV was detected. Recently tested 1-β-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5′-triphosphate (ribavirin 5′-triphosphate) appeared a moderate HCV and WNV NTPase/helicase inhibitor (Borowski et al., 2000) . In our previous studies we demonstrated that FSBA inhibited efficiently both the NTPase and helicase of the WNV NTPase/helicase, and only slightly the activities of the HCV enzyme (Borowski et al., 2001) . It is noteworthy that this inhibition occurred after preincubation of FSBA with the enzymes. A pre-incubation was necessary for covalent binding of the fluorosulphonylbenzoyl residue to the conserved lysine within the ATP-binding sites of numerous proteins (Colman, 1983) .
On the basis of the foregoing results, it seemed interesting to synthesize 5′-O-(4-fluorosulphonylbenzoyl) esters of ribavirin (FSBR), inosine (FSBI), guanosine (FSBG), and adenosine (FSBA), and to examine their activities against RNA NTPase/helicases of HCV, WNV, JEV and DENV, along with polymerases of HCV and of WNV.
Materials and methods: chemistry

General methods
Melting points (uncorrected) were measured on a Büchi B-540 apparatus. UV spectra were recorded on a Cary 300 instrument, using 10-mm path length cuvettes. High resolution mass spectra were recorded on electrospray Q-TOF MICROMASS spectrometer.
1 H NMR spectra were measured on 500 MHz Varian UX-NMR spectrometer in DMSO-d 6 . Chemical shifts are reported in ppm units with tetramethylsilane as an internal standard. Thin layer chromatography (TLC) was run on Merck silica gel F 254 glass plates (DC, 20×20 cm, 0.25 mm; no. 1.05718) in CHCl 3 -MeOH, 85:15.
Materials
1-β-D-Ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) was from Sigma no 9644.
5'-O-(4-fluorosulphonylbenzoyl)-ribavirin (FSBR, 1).
Ribavirin (122 mg, 0.5 mmol) was dissolved in 1 ml HMPA and 187 mg (0.85 mmol) of 4-fluorosulphonylbenzoyl chloride (FSBCl) was added in small portions. The mixture was stirred for 20 h, and the product was precipitated by the addition of 10 ml of ether. Crystallization from ethanol gave 118 mg of product (0.27 mmol, 55% yield) with a melting point 169-170°C. UV (MeOH): λ max 228 nm (ε 15200), 282 nm (ε, 1034); 
5'-O-(4-fluorosulphonylbenzoyl)-adenosine (FSBA, 2).
2 was synthesized using the procedure of Wyatt & Colman (1977) 
5'-O-(4-fluorosulphonylbenzoyl)-guanosine (FSBG, 3).
FSBG was synthesized as described above: UV pH 6 λ max 233 nm (ε 20 400), 239 nm (ε 19 500) and shoulders at 252 nm (ε 14 300), and 275 (ε 9700), 
5'-O-(4-fluorosulphonylbenzoyl)-inosine (FSBI, 4).
4 was synthesized using the procedure described for FSBA (Wyatt & Colman, 1977) with some purification modifications.
Inosine (268 mg, 1 mmol) was dissolved in 2 ml of HMPA with slight warming. The solution was cooled in an ice bath and 310 mg (1.4 mmol) FSBCl was added in small portions. The mixture was stirred at room temperature for 20 h, and then extracted with petroleum ether. The upper layer was discarded and the product was precipitated by the addition of 10 ml of ethyl acetate-ether (1:1) to the lower layer. The resulting yellowish oil was further washed twice with ethyl acetate-ether and dissolved in 15 ml of warm water. Crystallization occurred at room temperature overnight and the product was dried in vacuo with a yield of 50%; 
Materials and methods: biology Enzymes
The WNV NTPase/helicase was purified from the medium harvested from cultures of WNV-infected Vero E6 cells as previously described (Borowski et al., 2001) .
The NTPase/helicase domains of HCV, JEV and DENV were expressed in Escherichia coli and purified as previously described (Kim et al., 1995) . The amino acid sequence of the HCV NTPase/helicase was previously referred to as HCV-1 (Genbank accession number M62321). The final preparation contained homogeneous NTPase/helicase when analysed in SDS polyacrylamide gel stained with Coomassie Blue.
HCV and WNV polymerases were expressed in baculovirus and purified as described previously (Behrens et al., 1996; Steffens et al., 1999) .
Helicase assay
The helicase activity was assayed with 2 pmol of enzyme incubated in the reaction mixture (final volume 25 µl) containing 20 µM Tris/HCl (pH 7.5), 2 mM MgCl 2 , 1 mM β-mercaptoethanol, 10% glycerol, 0.01% Triton X-100, 0.1 mg/ml BSA, 4.7 pM DNA substrate and ATP at a concentration corresponding to the K m value determined for the ATPase reaction. The reaction proceeded for 30 min at 30°C and was stopped by addition of 5 µl of termination buffer. The reaction mixtures were subjected to electrophoresis on 15% polyacrylamide TBE gel containing 0.1% SDS. The gels were dried and exposed to Kodak Xray films at -70°C. Subsequently, the parts of the gels corresponding to the released strand and double-stranded substrate were cut out and the 32 P radioactivity was determined by counting of Cerenkov radiation. Alternatively, the films were scanned and the radioactivity was quantified with GelImage software.
The substrate for the helicase assay was obtained by annealing the two complementary DNA oligonucleotides. The released strand (26-mer) was 5′-end labelled with [γ-32 P]ATP using T4 polynucleotide kinase, according to the procedure described previously (Borowski et al., 2001) . 
ATPase assay
The assay was performed with 2 pmol of NTPase/helicase incubated in a reaction mixture (final volume 25 µl) that contained 20 mM Tris/HCl (pH 7.5), 2 mM MgCl 2 , 1 mM β-mercaptoethanol, 10% glycerol, 0.01% Triton X-100, 0.1 mg/ml BSA, 9.5 µM [γ-32 P] ATP (0.025 µCi) and ATP adjusted to the K m value. The reaction proceeded for 30 min at 30°C and was terminated by the addition of 0.5 ml of suspension of activated charcoal (2 mg/ml). After centrifugation at 10000×g for 10 min, 100 µl of the supernatant was subjected to scintillation counting.
Polymerase assay
The polymerase activity was determined according to the method described by Yuan et al. (1997) , with some modifications. Briefly, 0.5 pmol enzyme was added to the reaction mixture (30 µl) containing 25 mM Tris/HCl, 1 mM EDTA, 5 mM DTT, 6 mM MgCl 2 , 0.5 µCi of [α-32 P]UTP or [α-32 P]GTP, 50 µM each of the remaining NTPs (ATP, CTP and GTP) or (ATP, CTP and UTP) and 20 µg of a mixture of homopolymeric primer-template (polyA, polyC, polyU, and polyG). After 120 min at 30°C, 15 ml of the reaction mixture was applied on 1 cm 2 squares of Whatmann 3MM paper. The squares were then immersed into 10% cold TCA and washed twice with 10% TCA and ethanol. The incorporated 32 P was measured by counting of Cerenkov radiation.
Results
FSBR (1), FSBA (2), FSBG (3) and FSBI (4) were synthesized by acylation of the 5′-OH of ribavirin, adenosine, guanosine and inosine with 4-fluorosulphonylbenzoyl chloride (FSBCl) in hexamethylphosphoric triamide (HMPA) (Figure 1) , with some modifications of the method previously described (Pal et al., 1975; Chern et al., 1993) , giving better yields than reported. The spectral properties of compounds 2, 3 and 4 were consistent with those previously reported (Pal et al., 1975; Pal et al. 1978; Williamsom & Meister, 1982) .
When the helicase activity of the HCV NTPase/helicase was tested as a function of increasing concentrations of the 5′-O-FSB esters under standard reaction conditions (for example, the compounds were added at the start of the reaction), noteworthy inhibition of the unwinding activity was obtained only with FSBI (IC 50 =120 µM). In case of FSBR and FSBA, modest inhibition with an IC 50 ranging between 500 µM and 1 mM was observed, whereas FSBG stimulated the helicase activity (Figure 2A ). After preincubation of the HCV NTPase/helicase with the 5′-O-FSB derivatives, all the compounds displayed an inhibitory effect ( Figure 3A) , and the inhibition was strongly dependent on the time of exposure to the compounds.
Comparative studies were carried out with the NTPase/helicases of selected flaviviruses -WNV, JEV, and DENV. When the assays were performed with enzymes without preincubation with the 5′-O-FSB nucleosides, no significant inhibition was observed (IC 50 values ranged between 500 µM and 2 mM) ( Figure 2B-D) . However, after preincubation for 90 or 180 min, a dramatic increase of the inhibitory potential of the compounds towards the helicase activity of the WNV and JEV NTPase/helicases was seen ( Figure 3B,C) , and in case of JEV enzyme even total inhibition of the helicase activity was observed after preincubation with FSBI. In the case of DENV enzyme the effect of the preincubation was weaker ( Figure 3D ).
Generally, it was observed that the enzymes of the flavivirus genus are more susceptible to the nucleoside 5′-O-FSB derivatives mediated inhibition (after the preincubation) than those of the hepacivirus, HCV. The data are summarized and juxtaposed (HCV NTPase/helicase versus enzymes of flaviviruses) in Table 1 . However, within the group of the closely related NTPase/helicases of the selected flaviviruses, the extent of the inhibition was enzyme specific. For example, in contrast to the JEV NTPase/helicase, it was observed that the unwinding activity of the DENV NTPase/helicase was only modestly reduced after preincubation for 90 min and could not be completely inhibited after 180 min and even longer preincubation of the enzyme with the nucleoside 5′-O-FSB derivatives.
Although a general tendency in the activity of the inhibitors is rather difficult to recognize, FSBI appears to be the most potent inhibitor in case of preincubation for 180 min of the enzymes with the compound ( Figure  3A-D) . When the 5′-FSB esters were tested under standard reaction conditions as inhibitors of the ATPase activity of the NTPase/helicases, no effect on ATP hydrolysis was observed up to 1 mM concentrations of the compounds. Interestingly, when the enzymes were preincubated for 180 min with the 5′-O-FSB nucleosides prior to the start of the ATPase reaction, a very different effect was observed. Whereas the ATPase activity of the WNV could be completely blocked by all compounds, and that of JEV partially so [FSBA: 65% inhibition; FSBG: 80% inhibition; FSBI: 40% inhibition and FSBR: 25% inhibition (in each case applied at 500 µM)], the compounds did not cause any measurable inhibition of the ATPase activity of HCV and DENV enzymes. Only excessive long preincubation (>360 min) led to noteworthy inhibition of the ATPase activity of the enzymes (data not shown).
Subsequently, the 5′-O-FSB derivatives were tested as inhibitors of the second key enzyme of the Flaviviridae replication complex, the RdRp. With α-labelled 5′-UTP and/or GTP, the polymerases of HCV and WNV, under standard reaction conditions, exhibited only weak inhibition with FSBI, with IC 50 values ranging between 70 µM and 600 µM. Other 5′-O-FSB derivatives had a marginal inhibitory effect on the enzymes. In the case of FSBR, the IC 50 values ranged between 330 µM and >1 mM. FSBA and FSBG failed to show any inhibitory activity. Preincubation of the enzymes with the 5′-O-FSB derivatives prior to the start of the reaction did not increase the extent of the inhibition (Table 2) .
Discussion
The 5′-O-FSB ester of adenosine, FSBA, was previously successfully used as a blocker of the ATP-binding site(s) of various proteins, and, therefore, as an inhibitor of enzymatic activities of a broad range of enzymes requiring ATP and other NTPs (Colman, 1983) . Nevertheless, the obvious differences between the inhibition of the helicase and NTPase activities of the Flaviviridae NTPase/helicases investigated imply that the 5′-O-FSB derivatives inhibit the enzymes Figure 3 . The values represent the residual helicase activity of the enzymes measured after the NTPase/helicases were exposed to 5′-O-FSB derivatives for 180 min. The results shown are representative of three independent experiments.
by a mechanism that is different or additional to the blockade of NTP-binding and hydrolysing site of the enzymes. The mechanism of inhibition could be well explained by the presence of an allosteric regulatory site within the NTPase/helicase molecule, which might be occupied by the 5′-O-FSB derivatives. The presence of such a nucleotidebinding site within HCV NTPase/helicase was previously demonstrated by Porter (1998) . Somewhat surprising was the generally weak inhibition of the NTPase activity of the investigated enzymes, even after their extensive preincubation with the tested compounds. The result appears to be in contrast to our previous observations that the isolated NTP-binding domain (domain 1) of HCV NTPase/helicase readily binds FSBA (Borowski et al., 1999) . The biochemical basis of this phenomenon remains uncertain. Apparently the Walker motifs, present in domain 1 and responsible for the binding of the phosphate groups of β-and γ-NTP, did not recognize the FSB-moiety, and the covalent binding of FSBA occurred at a site that does not interfere with the binding and hydrolysis of the triphosphate groups of ATP. Although there have been reports demonstrating the binding and, consequently, inhibition of different polymerases by FSBA, nucleoside 5′-O-FSB derivatives proved to be only weak inhibitors of the HCV and WNV RdRps.
Although we could demonstrate, at least in some cases, that the 5′-O-FSB derivatives inhibit the enzymes of the Flaviviridae replication complex, the application of the compounds in vivo appears to be very limited. In a broad range of cases it was demonstrated that FSBA blocks the NTP-binding site of cell enzymes by binding covalently via its FSB moiety. This could make the compounds toxic under in vivo conditions. Nevertheless, our findings show that among the 5′-O-FSB derivatives, FSBI possesses the highest inhibitory potential. This makes the base of this nucleoside Tas a start point for the development of nucleotide-derived inhibitors of the enzymes of replication complex. The polymerase activity was determined as function of increasing concentrations of FSBA, FSBG, FSBI and FSBR and the inhibitory potential of the compounds was expressed as the inhibitor concentration at which 50% activity was measured (IC 50 ). The inhibitory effect of preincubation was determined with an enzyme exposed to various concentrations of 5′-O-FSB derivatives for 90 min. The reaction was started by addition of the substrates and proceeded as described in Materials and methods. The results shown are representative of three independent experiments.
